Literature DB >> 10872478

Sickle cell disease: clinical management.

S K Ballas1.   

Abstract

Sickle cell syndromes are a group of inherited disorders of haemoglobin structure that have no cure in adults at the present time. Bone marrow transplantation in children has been shown to be curative in selected patients. The phenotypic expression of these disorders and their clinical severity vary greatly among patients and longitudinally in the same patient. They are multisystem disorders and influence all aspects of the life of affected individuals including social interactions, family relations, peer interaction, intimate relationships, education, employment, spiritual attitudes and navigating the complexities of the health care system, providers and their ancillary functions. The clinical manifestations of these syndromes are protean. In this review emphasis is placed on four sets of major complications of these syndromes and their management. The first set pertains to the management of anaemia and its sequelae; the second set addresses painful syndromes both acute and chronic; the third set discusses infections; the fourth section deals with organ failure. New experimental therapies for these disorders are briefly mentioned at the end. Efforts were made to include several tables and figures to clarify the message of this review.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10872478     DOI: 10.1016/s0950-3536(98)80075-9

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  7 in total

1.  Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.

Authors:  Ashaunta Tumblin; Anitaben Tailor; Gerard T Hoehn; A Kyle Mack; Laurel Mendelsohn; Lita Freeman; Xiuli Xu; Alan T Remaley; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

Review 2.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

3.  Tuberculous spondylodiscitis in a patient with a sickle-cell disease: CT findings.

Authors:  Leszek Krupniewski; Piotr Palczewski; Marek Gołębiowski; Katarzyna Kosińska-Kaczyńska
Journal:  Pol J Radiol       Date:  2012-01

4.  The challenge of differentiating vaso-occlusive crises from osteomyelitis in children with sickle cell disease and bone pain: A 15-year retrospective review.

Authors:  A Fontalis; K Hughes; M P Nguyen; M Williamson; A Yeo; D Lui; Y Gelfer
Journal:  J Child Orthop       Date:  2019-02-01       Impact factor: 1.548

Review 5.  Sickle cell anaemia: progress in pathogenesis and treatment.

Authors:  Samir K Ballas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Sickle cell disease: management options and challenges in developing countries.

Authors:  Daniel Ansong; Alex Osei Akoto; Delaena Ocloo; Kwaku Ohene-Frempong
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

7.  Sickle cell disease and pregnancy: analysis of 34 patients followed at the Regional Blood Center of Ribeirão Preto, Brazil.

Authors:  Ana Cristina Silva-Pinto; Simery de Oliveira Domingues Ladeira; Denise Menezes Brunetta; Gil Cunha De Santis; Ivan de Lucena Angulo; Dimas Tadeu Covas
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.